Prudential Financial Inc Allakos Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $170,546 - $2.23 Million	-19,947 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $800,962 - $1.16 Million	10,466 Added 110.39%	19,947 $2.11 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $48,660 - $65,037	570 Added 6.4%	9,481 $810,000
Q1 2021 May 12, 2021	BUY	$109.73 - $153.66 $762,733 - $1.07 Million	6,951 Added 354.64%	8,911 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $155,976 - $298,802	1,960 New	1,960 $274,000

68.8M

20.9K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.